학술논문

821TiP Phase I study of ceralasertib (cerala) in combination with AZD5305 in patients (pts) with advanced/metastatic ovarian cancer (OC) previously treated with PARP inhibitors (PARPis)
Document Type
Abstract
Source
In Annals of Oncology October 2023 34 Supplement 2:S542-S542
Subject
Language
ISSN
0923-7534